.Neurocrine Biosciences has actually attained its hoped-for account in a phase 2 schizophrenia trial...
.Vaderis Therapeutics' target to build the 1st medicine aimed specifically at a specific unusual cap...
.Navigator Medicines has furnished on its own along with $one hundred million in collection A funds ...
.China's Duplicity Biotherapeutics has submitted (PDF) documentation for a Hong Kong IPO, looking fo...
.4 months after Chinese genetics modifying business YolTech Therapeutics took its cholesterol levels...
.Indivior is picking up a little molecule allosteric modulator designed to alleviate substance use a...
.Molecular Partners has determined "suboptimal exposure" to its own tetra-specific T-cell engager as...